-
Inarigivir soproxil
- names:
Inarigivir soproxil
- CAS号:
942123-43-5
MDL Number: - MF(分子式): C25H34N7O13PS MW(分子量): 703.62
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM000560-10mg | 10mg | 98.16% | ¥ 11475.00 | ¥ 11475.00 | 2-3天 | ¥ 0.00 | ||
| YZM000560-5mg | 5mg | 98.16% | ¥ 7150.00 | ¥ 7150.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | |
| CAS号 | 942123-43-5 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C25H34N7O13PS |
| 分子量 Molecular Weight | 703.62 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度≥ 102 mg/mL(144.96 mM)*"≥" means soluble可溶, but saturation unknown溶解度未知. |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
Inarigivir soproxil(CAS:942123-43-5)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | Inarigivir soproxil 为先天免疫的激动剂,显示了对丙型肝炎病毒(HCV)耐药突变型有良好的抗病毒活性,在细胞中测得其对 HCV 1a/1b 两种突变型的EC50值分别为 2.2 μM 和 1.0 μM |
| Introduction | Inarigivir soproxil is an agonist of innate immunity and shows potent antiviral activity against resistant hepatitis C virus(HCV)variants, withEC50sof 2.2 and 1.0 μM for HCV 1a/1b in cells of genotype 1 HCV replicon systems. |
| Application1 | |
| Application2 | |
| Application3 |
Inarigivir soproxil 为先天免疫的激动剂,显示了对丙型肝炎病毒(HCV)耐药突变型有良好的抗病毒活性,在细胞中测得其对 HCV 1a/1b 两种突变型的EC50值分别为 2.2 μM 和 1.0 μM。Inarigivir soproxil is an agonist of innate immunity and shows potent antiviral activity against resistant hepatitis C virus(HCV)variants, withEC50sof 2.2 and 1.0 μM for HCV 1a/1b in cells of genotype 1 HCV replicon systems.
【1】.Jones M, ET AL. SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants. J Med Virol. 2017 Sep;89(9):1620-1628.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


